Belgian COVID-19 patient re-infected only three months after the initial infection
A Belgian patient had COVID-19 twice. She was reinfected 93 days after the first infection and experienced symptoms in both occasions.
Top researcher and British COVID-19 key expert joins UCPH from Imperial College
The English researcher and disease-modeling expert Dr. Samir Bhatt will soon join University of Copenhagen. From his position at Imperial College London
Westminster alumnus-led vaccine manufacturer set to play leading role in large scale production of...
Westminster alumnus Adar Poonawalla, who is the CEO of the world’s largest vaccine manufacturer called Serum Institute of India...
Update on AIT during Global Coronavirus Crisis
Since January of this year, the Coronavirus (COVID-19) crisis has spread across the world. By the end of August, the situation is excellent in Thailand
The Novel Coronavirus: Facts and Fictions
While growing concerns have allowed for a more effective implementation of social distancing measures, mounting disinformation puts people at risk of unwittingly...
UvA launches new research project on how to design tax systems for a post...
Today, the University of Amsterdam (UvA) announced the launch of the research project “Designing the tax system for a Cashless...
Why Covid elimination remains the best game-plan
Here in Aotearoa, we’re playing Covid-19 in “elimination” mode. Some countries are trying “suppression” mode, while others are running with...
HKUMed researchers discovered that ORF8 and ORF3b
Researchers from HKU-Pasteur Research Pole at the School of Public Health, LKS Faculty of Medicine of The University of Hong Kong used Luciferase Immunoprecipitation System...
How COVID-19 and bushfires impacted new mums and babies
A new survey developed by The Australian National University (ANU) will examine the effects of this year's bushfires and COVID-19 on pregnant women and their babies.
Nanoparticles show promise in defeating antibiotic-resistant bacteria, U of T researchers find
A new therapy developed by researchers at the University of Toronto may bring us one step closer to effectively killing deadly drug-resistant superbugs.
- Advertisement -
